| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |